Trial
NCT00794963
Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
—
Condition
Metabolic Syndrome
Intervention
Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan
Why stopped
Difficulty recruiting
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-15